Oral contraceptives lower ovarian cancer risk in BRCA carriers

Vietnam orders virus lockdown in Ho Chi Minh City
7 July 2021
Immunocompromised? Why the COVID-19 vaccine might still protect you
7 July 2021

Oral contraceptives lower ovarian cancer risk in BRCA carriers

(HealthDay)—Oral contraceptive use is associated with a reduced risk for ovarian cancer for BRCA mutation carriers, according to a study published in the July issue of the American Journal of Obstetrics & Gynecology.

Comments are closed.